{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,15]],"date-time":"2026-03-15T09:35:40Z","timestamp":1773567340532,"version":"3.50.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[1988,6,1]],"date-time":"1988-06-01T00:00:00Z","timestamp":581126400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur Arch Psychiatr Neurol Sci"],"published-print":{"date-parts":[[1988,6]]},"DOI":"10.1007\/bf00449905","type":"journal-article","created":{"date-parts":[[2004,11,13]],"date-time":"2004-11-13T04:30:38Z","timestamp":1100320238000},"page":"189-193","source":"Crossref","is-referenced-by-count":9,"title":["Effects of 4 weeks treatment with chlorpromazine and\/or trihexyphenidyl on the pituitary-gonadal axis in male paranoid schizophrenics"],"prefix":"10.1007","volume":"237","author":[{"given":"Pantelis","family":"Rinieris","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Hatzimanolis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manolis","family":"Markianos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Costas","family":"Stefanis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/0014-2999(70)90006-3","volume":"11","author":"NE Anden","year":"1970","unstructured":"Anden NE, Butcher SG, Corrodi H, Fuxe K, Ungerstedt U (1970) Receptor activity and turnover of dopamine and noradrenaline after neuroleptics. Eur J Pharmacol 11:303?314","journal-title":"Eur J Pharmacol"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/j.2042-7158.1972.tb08961.x","volume":"24","author":"NE Anden","year":"1972","unstructured":"Anden NE, Corrodi H, Fuxe K (1972) Effect of neuroleptic drugs on central catecholamine turnover assessed using tyrosine- and dopamine-?-hydroxylase inhibitors. J Pharm Pharmacol 24:177?182","journal-title":"J Pharm Pharmacol"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1176\/ajp.140.12.1588","volume":"140","author":"A Apter","year":"1983","unstructured":"Apter A, Dickerman Z, Gonen N, Assa S, Prager-Lewin R, Kaufman H, Tyano S, Laron Z (1983) Effect of chlorpromazine on hypothalamic-pituitary-gonadal function in 10 adolescent schizophrenic boys. Am J Psychiatry 140:1588?1591","journal-title":"Am J Psychiatry"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/0306-4530(81)90032-9","volume":"6","author":"O Benkert","year":"1981","unstructured":"Benkert O, Klein HE, Hofschuster E, Seibold C (1981) Effect of the anticholinergic drug biperiden on pituitary hormones and cortisol. Psychoneuroendocrinology 6:231?238","journal-title":"Psychoneuroendocrinology"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/BF00421177","volume":"44","author":"F Brambilla","year":"1975","unstructured":"Brambilla F, Guerrini A, Guastalla A, Rovere C, Riggi F (1975) Neuroendocrine effects of haloperidol therapy in chronic schizophrenia. Psychopharmacologia 44:17?22","journal-title":"Psychopharmacologia"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/0196-9781(82)90092-4","volume":"3","author":"L Cass Terry","year":"1982","unstructured":"Cass Terry L, Crowley WR, Lynch C, Longserre C, Johnson MD (1982) Role of central epinephrine in regulation of anterior pituitary hormone secretion. Peptides 3:311?318","journal-title":"Peptides"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1210\/jcem-41-5-981","volume":"41","author":"R Collu","year":"1975","unstructured":"Collu R, J\u00e9quier JC, Leboeuf G, Letarte J, Ducharme JR (1975) Endocrine effects of pimozide, a specific dopaminergic blocker. J Clin Endocrinol Metab 41:981?984","journal-title":"J Clin Endocrinol Metab"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/0306-4530(82)90038-5","volume":"7","author":"BM Davis","year":"1982","unstructured":"Davis BM, Brown GM, Miller M, Friesen HG, Kastin AJ, Davis KL (1982) Effects of cholinergic stimulation on pituitary hormone release. Psychoneuroendocrinology 7:347?354","journal-title":"Psychoneuroendocrinology"},{"key":"CR9","first-page":"29","volume-title":"Neuroendocrinology and psychiatric disorder","author":"JM Davis","year":"1984","unstructured":"Davis JM, Vogel C, Gibbons R, Pavkovic I, Zhang M (1984) Pharmacoendocrinology of schizophrenia. In: Brown GM, Koslow SH, Reichlin S (eds) Neuroendocrinology and psychiatric disorder. Raven, New York, pp 29?53"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/j.1365-2265.1976.tb01953.x","volume":"5","author":"JL DeRivera","year":"1976","unstructured":"DeRivera JL, Lal S, Ettigi P, Hontella S, Muller HF, Friesen HG (1976) Effect of acute and chronic neuroleptic therapy on serum prolactin levels in men and women of different age groups. Clin Endocrinol 5:273?282","journal-title":"Clin Endocrinol"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1210\/endo-99-3-651","volume":"99","author":"SV Drouva","year":"1976","unstructured":"Drouva SV, Gallo RV (1976) Catecholamine involvement in episodic luteinizing hormone release in adult ovariectomized rats. Endocrinology 99:651?658","journal-title":"Endocrinology"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/BF00433807","volume":"72","author":"U Halbreich","year":"1980","unstructured":"Halbreich U, Sachar EJ, Nathan RS, Asnis GM, Halpern FS (1980) The effect of benztropine mesylate on the prolactin response to haloperidol. Psychopharmacology 72:61?65","journal-title":"Psychopharmacology"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1007\/BF00408332","volume":"9","author":"TE Hanlon","year":"1966","unstructured":"Hanlon TE, Schoenrich C, Freinek W, Turek I, Kurland AA (1966) Perphenazine-benztropine mesylate treatment of newly admitted psychiatric patients. Psychopharmacologia 9:328?339","journal-title":"Psychopharmacologia"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/BF00427479","volume":"49","author":"T Kolakowska","year":"1976","unstructured":"Kolakowska T, Wiles DH, Gelder MG, McNeilly AS (1976) Clinical significance of plasma chlorpromazine levels. Psychopharmacology 49:101?107","journal-title":"Psychopharmacology"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/j.1600-0447.1977.tb00174.x","volume":"55","author":"M Krawiecka","year":"1977","unstructured":"Krawiecka M, Goldberg D, Vaughan M (1977) A standardized psychiatric assessment scale for rating chronic psychotic patients. Acta Psychiatr Scand 55:299?308","journal-title":"Acta Psychiatr Scand"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1146\/annurev.ph.41.030179.003131","volume":"41","author":"L Krulich","year":"1979","unstructured":"Krulich L (1979) Central neurotransmitters and the secretion of prolactin, GH, LH and TSH. Annu Rev Physiol 41:603?615","journal-title":"Annu Rev Physiol"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1159\/000117699","volume":"5","author":"S Lal","year":"1979","unstructured":"Lal S, Mendis T, Cervantes P, Guyda H, DeRivera JL (1979) Effect of benztropine on haloperidol-induced prolactin secretion. Neuropsychobiology 5:327?331","journal-title":"Neuropsychobiology"},{"key":"CR18","first-page":"93","volume-title":"Clinical neuroendocrinology","author":"JB Martin","year":"1977","unstructured":"Martin JB, Reichlin S, Brown GM (1977) Neuroendocrinology of reproduction. In: Martin JB, Reichlin S, Brown GM (eds) Clinical neuroendocrinology. Davis, Philadelphia, pp 93?128"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/0306-4530(78)90015-X","volume":"3","author":"R Martin-DuPan","year":"1979","unstructured":"Martin-DuPan R, Baumann P, Magrini G, Felber JP (1979) Neuroendocrine effects of chronic neuroleptic therapy in male psychiatric patients. Psychoneuroendocrinology 3:245?252","journal-title":"Psychoneuroendocrinology"},{"key":"CR20","first-page":"1","volume-title":"Neuroendocrinology and psychiatric disorder","author":"HY Meltzer","year":"1984","unstructured":"Meltzer HY (1984) Neuroendocrine abnormalities in schizophrenia: prolactin, growth hormone, and gonadotrophins. In: Brown GM, Koslow SH, Reichlin S (eds) Neuroendocrinology and psychiatric disorder. Raven, New York, pp 1?28"},{"key":"CR21","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/j.1365-2265.1982.tb01599.x","volume":"17","author":"K Nakagawa","year":"1982","unstructured":"Nakagawa K, Obara T, Matsubara M, Kubo M (1982) Relationship of changes in serum concentrations of prolactin and testosterone during dopaminergic modulation in males. Clin Endocrinol 17:345?352","journal-title":"Clin Endocrinol"},{"key":"CR22","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/S0140-6736(80)92977-3","volume":"II","author":"RS Nathan","year":"1980","unstructured":"Nathan RS, Asnis GM, Dyrenfurth I, Halpern FS, Halbreich U, Ostrow LC, Sachar EJ (1980) Plasma prolactin and testosterone during penfluridol treatment. Lancet II:94","journal-title":"Lancet"},{"key":"CR23","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.1600-0447.1975.tb11093.x","volume":"51","author":"HM Praag van","year":"1975","unstructured":"Praag HM van, Korf J (1975) Biochemical research into psychosis. Acta Psychiatr Scand 51:268?284","journal-title":"Acta Psychiatr Scand"},{"key":"CR24","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1002\/cpt1973146978","volume":"14","author":"L Rivera-Calimlim","year":"1973","unstructured":"Rivera-Calimlim L, Castaneda L, Lasagna L (1973) Effects of mode of management on plasma chlorpromazine in psychiatric patients. Clin Pharmacol Ther 14:978?986","journal-title":"Clin Pharmacol Ther"},{"key":"CR25","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0306-4530(80)90015-3","volume":"5","author":"RT Rubin","year":"1980","unstructured":"Rubin RT, Hays SE (1980) The prolactin secretory response to neuroleptic drugs: mechanisms, applications and limitations. Psychoneuroendocrinology 5:121?137","journal-title":"Psychoneuroendocrinology"},{"key":"CR26","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1210\/endo-86-5-988","volume":"86","author":"L Rubinstein","year":"1970","unstructured":"Rubinstein L, Sawyer CH (1970) Role of catecholamines in stimulating the release of pituitary ovulating hormones in rats. Endocrinology 86:988?995","journal-title":"Endocrinology"},{"key":"CR27","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1159\/000117667","volume":"5","author":"MM Singh","year":"1979","unstructured":"Singh MM, Kay SR (1979) Therapeutic antagonism between anticholinergic antiparkinsonism agents and neuroleptics in schizophrenia. Neuropsychobiology 5:74?86","journal-title":"Neuropsychobiology"},{"key":"CR28","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1176\/ajp.137.9.1130","volume":"137","author":"SG Siris","year":"1980","unstructured":"Siris SG, Siris ES, Kammen DP van, Docherty JP, Alexander PE, Bunney WE (1980) Effects of dopamine blockade on gonadotropins and testosterone in men. Am J Psychiatry 137:211?214","journal-title":"Am J Psychiatry"},{"key":"CR29","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1111\/j.1600-0447.1977.tb00229.x","volume":"56","author":"B Wode-Helgodt","year":"1977","unstructured":"Wode-Helgodt B, Eneroth P, Fyr\u00f6 B, Gullberg B, Sedvall G (1977) Effect of chlorpromazine treatment on prolactin levels in cerebrospinal fluid and plasma of psychotic patients. Acta Psychiatr Scand 56:280?293","journal-title":"Acta Psychiatr Scand"}],"container-title":["European Archives of Psychiatry and Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00449905.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00449905\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00449905","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,30]],"date-time":"2023-04-30T05:56:31Z","timestamp":1682834191000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00449905"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1988,6]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1988,6]]}},"alternative-id":["BF00449905"],"URL":"https:\/\/doi.org\/10.1007\/bf00449905","relation":{},"ISSN":["0175-758X","1433-8491"],"issn-type":[{"value":"0175-758X","type":"print"},{"value":"1433-8491","type":"electronic"}],"subject":[],"published":{"date-parts":[[1988,6]]}}}